Genmab A/S.
GMAB.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Genmab A/S is a biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer and other diseases. The company's primary focus is on researching, developing, and manufacturing antibody-based products. Genmab utilizes its proprie...Show More
Better Health for All
10
Genmab's core business is dedicated to developing antibody therapeutics for cancer and other diseases, with two co-owned medicines on the market, six others developed by partners, and nine products in clinical development, indicating that 100% of its portfolio delivers revolutionary health benefits.
1
The company invested 75% of its cumulative $33.8 billion from 2017 to 2023 in R&D, with a 37% increase in 2023 over 2022, demonstrating significant investment in health innovation.
2
Genmab has a Clinical Trial Transparency Declaration and a Diversity, Equity & Inclusion (DE&I) Clinical Trials Committee, with 907 patients enrolled in clinical trials across 32 countries in 2023.
3
The company appointed an external Data Protection Officer and adopted IFPMA Data Ethics principles, reporting no substantiated data privacy complaints in 2023.
4
Genmab launched a mental health application, GenCare, used by over 50% of team members globally, with over 80% finding it impactful.
5
However, the company's Scope 1, 2, and 3 GHG emissions totaled 147,721 tons CO2e in 2022, with a commitment to only a 42% reduction in Scope 1 and 2 by 2030, and two-thirds of suppliers by spend covered by Paris Agreement aligned climate targets for Scope 3.
6
While business continuity plans are in place for health crises, there is no evidence of specific contributions or donations during emergencies.
7
Fair Money & Economic Opportunity
0
No evidence available to assess Genmab A/S on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
20
In 2024, the Chief Executive Officer's total remuneration was 75.5 DKK million.
1
The average employee remuneration for the Group in the same year was 1.58 DKK million, resulting in a CEO to average employee pay ratio of approximately 47.78:1.
2
Fair Trade & Ethical Sourcing
0
The provided article does not contain any information related to GMAB.US or the ethical value of Fair Trade & Ethical Sourcing.
1
Therefore, no data points could be extracted to assess performance against the specified KPIs.
2
Honest & Fair Business
0
Genmab has a comprehensive Global Speak Up Policy, effective June 2024, which applies to all personnel and contingent workers globally.
1
It offers 24/7 anonymous reporting via an independently-operated hotline (NAVEX/Ethicspoint) and other channels, with a strict zero-tolerance policy for retaliation.
2
The Audit and Finance Committee receives annual summaries and quarterly updates on significant matters.
3
The company also has a robust anti-corruption policy, prohibiting bribery and facilitation payments, and is subject to the U.S. FCPA.
4
This policy is integrated into its Code of Conduct, with annual training required for all employees and board members.
5
However, Genmab revised its 2022 and 2021 financial statements due to royalty overpayment issues with Janssen.
6
Additionally, 55.6% of the aggregate nine-member Board of Directors are considered independent, as the three employee-elected members are not deemed independent.
7
The Speak Up line is operated by an independent third party, but there is no broader evidence of independent verification of ethical claims.
8
Kind to Animals
-10
Genmab's external contractors are AAALAC International accredited or have comparable standards, and an internal animal facility (GDL) is also AAALAC and ISO9001:2000 accredited.
1
The company has an Animal Welfare Policy committing to ethical standards in research and development, operating in strict compliance with local, national, and international laws, including Directive 2010/63/EU and the US Animal Welfare Act.
2
This policy is overseen by a Global Animal Welfare Officer and Committee.
3
Genmab is a member of an industry consortium working on animal-free testing methods, but the evidence does not specify the level of contribution. The company monitors standards at contract research organizations through regular audits, with a special focus on animal welfare,
4
and as of 2022, all new suppliers are required to attest to their Supplier Code of Conduct annually.
5
No War, No Weapons
0
No relevant data was found in the provided article to assess GMAB.US against the 'No War, No Weapons' ethical value.
1
The article explicitly states it does not contain any data relevant to the company or the ethical value.
2
Planet-Friendly Business
-30
Genmab's total Scope 1, 2, and 3 greenhouse gas emissions were 189,673 tCO₂e in 2024, an increase from 151,463 tCO₂e in 2023.
1
The company does not have any disclosed or validated SBTi-aligned targets.
2
Respect for Cultures & Communities
0
No evidence available to assess Genmab A/S on Respect for Cultures & Communities.
Safe & Smart Tech
0
In 2019, 100% of employees received security training.
1
The company reported no incidents of unauthorized data use.
2
Genmab A/S stated compliance with relevant laws and regulations, including GLP, GCP, cGMP, and Danish, European, U.S., and Japanese regulations.
3
Zero Waste & Sustainable Products
0
No evidence available to assess Genmab A/S on Zero Waste & Sustainable Products.